Conferences - Results from #8320

ASCO - Bottom line: Timing of treatment with docetaxel for men with advanced prostate cancer - Session Highlights June 1, 2015

ASCO - Radium-223 linked to longer overall survival in international study of mCRPC patients with bone metastases - Session Highlights June 1, 2015

ASCO - Radium-223 early access program (EAP) enlightens safety, tolerability profile in a U.S. population of CRPC patients - Session Highlights June 1, 2015

#AUA15 - After 15 years, former smokers can lower their risk of recurrence of non-muscle invasive bladder cancer - Session Highlights May 26, 2015

#AUA15 - Futuristic stone “dusting” reduces kidney stones to a fine powder - Session Highlights May 26, 2015

#AUA15 - Older patients’ UTI symptoms may predict for bladder cancer, especially among women - Session Highlights May 21, 2015

#AUA15 - Active surveillance in Sweden: An example to follow? - Session Highlights May 21, 2015

#AUA15 - Point-Counterpoint: Refractory overactive bladder (OAB) with pelvic organ prolapse (POP) - Session Highlights May 20, 2015

#AUA15 - Durable reductions in urinary incontinence with long-term onabotulinumtoxinA treatment in patients with overactive bladder syndrome: Final results of 3.5-year study - Session Highlights May 20, 2015

#AUA15 - AUA Guideline: Interstitial cystitis guideline amendment - Session Highlights May 20, 2015

#AUA15 - Can multiparametric magnetic resonance imaging predict biochemical recurrence after radical prostatectomy? Implications for preoperative staging and surgical planning - Session Highlights May 20, 2015

#AUA15 - Debate: PCNL or URS for the 2 cm Stone - Session Highlights May 20, 2015

#AUA15 - Alkaline phosphatase velocity as a predictor of bone metastasis and overall survival in castrate resistant prostate cancer patients - Session Highlights May 20, 2015

#AUA15 - Budget impact analysis of enzalutamide for treatment of metastatic castration-resistant prostate cancer from a US payer perspective - Session Highlights May 20, 2015

#AUA15 - Patient understanding regarding end-of-life prostate cancer and perspectives regarding cost/benefit of current treatment paradigms - Session Highlights May 20, 2015

#AUA15 - Medical comorbidities, not neoadjuvant chemotherapy, affects decline in renal function following radical cystectomy and eligibility for platinum based adjuvant chemotherapy - Session Highlights May 20, 2015

#AUA15 - Neoadjuvant chemotherapy (NAC) has no adverse effect on radical cystectomy (RC) or perioperative complications - Session Highlights May 20, 2015

#AUA15 - White blood cell count at discharge following radical cystectomy associates with risk for readmission - Session Highlights May 20, 2015

#AUA15 - The severity of bowel dysfunction in patients with neurogenic bladder - Session Highlights May 19, 2015

#AUA15 - Medical complications and urological surveillance in the United States adult spina bifida population - Session Highlights May 19, 2015

Page 417 of 492

email news signup